about
Signaling pathways in the development of infantile hemangiomaThe risk of cancer in patients with rheumatoid arthritis taking tumor necrosis factor antagonists: a nationwide cohort study.Clinical features and management of multifocal hepatic hemangiomas in children: a retrospective studyBeta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation'Reduced malignancy as a mechanism for longevity in mice with adenylyl cyclase type 5 disruption'.The use of propranolol in the treatment of infantile haemangiomas: an update on potential mechanisms of action.The trophoblast model of cancer.β-Adrenergic modulation of cancer cell proliferation: available evidence and clinical perspectives.Role of G protein-coupled receptor kinase 2 in tumoral angiogenesis.
P2860
Q26996608-A8586FFD-0ACC-4077-84CA-9FCE349408FDQ34363241-4C7C9286-8472-428D-8EB6-19EBB3D3D398Q37181444-239037AA-E9F5-4A81-9F4C-E17B367B3CBCQ37565625-13157F13-458B-46B2-B1DE-F10B2DC5BF3FQ37693261-1CABEBE6-5FC6-4788-831E-76868F83E64CQ38246692-E2D328F7-78D6-4FEF-8602-D13F8A29824BQ38265246-7103727A-09E7-4E45-86E9-CE70BB968FCEQ38742275-EEFD3CB3-4F95-4BD3-A043-5CCA102E82C7Q38866740-344F8555-5E55-4AA4-8A13-002750928830
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
β-blockers: a novel class of antitumor agents.
@ast
β-blockers: a novel class of antitumor agents.
@en
type
label
β-blockers: a novel class of antitumor agents.
@ast
β-blockers: a novel class of antitumor agents.
@en
prefLabel
β-blockers: a novel class of antitumor agents.
@ast
β-blockers: a novel class of antitumor agents.
@en
P2093
P2860
P356
P1476
β-blockers: a novel class of antitumor agents.
@en
P2093
P2860
P304
P356
10.2147/OTT.S38403
P407
P577
2012-11-26T00:00:00Z